Global Artemisinin Market Analysis, Size, Application, Regional Outlook, Competitive Strategies and Forecasts To 2023
Artemisinin Market is expected to witness substantial growth over the forecast period owing to its increasing application scope in pharmaceutical industry.
(EMAILWIRE.COM, October 05, 2018 ) Market Overview:
Artemisinin Market is a sesquiterpene lactone containing a specific peroxide crosslinking that is the fastest acting of all current drugs against Plasmodium falciparum malaria. It is a plant Artemisia annua, sweet wormwood, isolated from the herb in Chinese traditional medicine. It can also be produced using genetically engineered yeast. Semi-synthetic derivatives of atemicinin have been developed because artemicinin itself has physical properties such as low bioavailability that limit its efficacy.
Market Growth Factors:
Artemisinin Market is expected to witness substantial growth over the forecast period owing to its increasing application scope in pharmaceutical industry. Demand for artemisinin has grown considerably over the past decade following the recognition of artemisinin based combination therapy (ACT) by WHO as a first line treatment for malaria. Increase in R&D activities and growing medical infrastructure particularly in emerging economies including China and India has triggered demand for artemisinin and its derivatives. Rising demand from malaria endemic countries such as Congo, Nigeria, Tanzania, Uganda and other South-East Asian countries including India is expected to drive market for artemisinin and its derivatives over the next six years. However, market for artemisinin is still in nascent stages owing to limited number of global manufacturers. In addition, lack of funding and programmatic uncertainties coupled with demand-supply gap are further expected to hamper market growth over the forecast period
Get free Sample Report @ https://www.research2reports.com/sample-report-medical-devices/artemisinin-market/52016
Market Segmentation:
Artemisinin Market is native to China and is effective against malaria parasites. Ongoing research and development has also shown that artemisinin and its derivatives are effective in treating cancer. The market is classified based on applications for malaria, cancer and parasitic parasite treatment. The largest application in 2017 was combination therapy based on artemisinin in malaria treatment. Markets can be segmented based on production mechanisms such as biosynthesis, chemical synthesis, and synthesis in engineered organisms. Intensive research is underway to develop a new, economical way to produce artemisinin.
Market Competitive Players:
Key companies that manufacture Artemisinin Market and its derivatives include Yeshua-Bio-Tech, Guilin Pharmaceutical Co. Ltd, Sanofi Aventis, Shanghai Desano Chemical Pharmaceutical Co. Ltd, Kunming Pharmaceutical Corporation, Calyx Pharmaceuticals and Chemicals and Mylan Laboratories Limited.
Market Regional Analysis:
Asia Pacific and Africa had the largest market share in the derivatives Artemisinin Market, with an increase in demand for artemisinin-based therapies in large-scale production bases of artemisinin herb and in malaria- It is because. North America has become the second largest market after Europe due to its well-developed healthcare industry and large number of pharmaceutical units.
Research Methodology
A research methodology focused on minimizing bias to provide the most accurate estimates and possible predictions. The company uses a combination of bottom-up and top-down approaches to segment and estimate quantitative aspects of the market. A common topic in all research reports is data triangulation, which looks at the market from three perspectives.
Enquiry before buy @ https://www.research2reports.com/enquiry-before-buy-medical-devices/artemisinin-market/52016
Artemisinin Market is a sesquiterpene lactone containing a specific peroxide crosslinking that is the fastest acting of all current drugs against Plasmodium falciparum malaria. It is a plant Artemisia annua, sweet wormwood, isolated from the herb in Chinese traditional medicine. It can also be produced using genetically engineered yeast. Semi-synthetic derivatives of atemicinin have been developed because artemicinin itself has physical properties such as low bioavailability that limit its efficacy.
Market Growth Factors:
Artemisinin Market is expected to witness substantial growth over the forecast period owing to its increasing application scope in pharmaceutical industry. Demand for artemisinin has grown considerably over the past decade following the recognition of artemisinin based combination therapy (ACT) by WHO as a first line treatment for malaria. Increase in R&D activities and growing medical infrastructure particularly in emerging economies including China and India has triggered demand for artemisinin and its derivatives. Rising demand from malaria endemic countries such as Congo, Nigeria, Tanzania, Uganda and other South-East Asian countries including India is expected to drive market for artemisinin and its derivatives over the next six years. However, market for artemisinin is still in nascent stages owing to limited number of global manufacturers. In addition, lack of funding and programmatic uncertainties coupled with demand-supply gap are further expected to hamper market growth over the forecast period
Get free Sample Report @ https://www.research2reports.com/sample-report-medical-devices/artemisinin-market/52016
Market Segmentation:
Artemisinin Market is native to China and is effective against malaria parasites. Ongoing research and development has also shown that artemisinin and its derivatives are effective in treating cancer. The market is classified based on applications for malaria, cancer and parasitic parasite treatment. The largest application in 2017 was combination therapy based on artemisinin in malaria treatment. Markets can be segmented based on production mechanisms such as biosynthesis, chemical synthesis, and synthesis in engineered organisms. Intensive research is underway to develop a new, economical way to produce artemisinin.
Market Competitive Players:
Key companies that manufacture Artemisinin Market and its derivatives include Yeshua-Bio-Tech, Guilin Pharmaceutical Co. Ltd, Sanofi Aventis, Shanghai Desano Chemical Pharmaceutical Co. Ltd, Kunming Pharmaceutical Corporation, Calyx Pharmaceuticals and Chemicals and Mylan Laboratories Limited.
Market Regional Analysis:
Asia Pacific and Africa had the largest market share in the derivatives Artemisinin Market, with an increase in demand for artemisinin-based therapies in large-scale production bases of artemisinin herb and in malaria- It is because. North America has become the second largest market after Europe due to its well-developed healthcare industry and large number of pharmaceutical units.
Research Methodology
A research methodology focused on minimizing bias to provide the most accurate estimates and possible predictions. The company uses a combination of bottom-up and top-down approaches to segment and estimate quantitative aspects of the market. A common topic in all research reports is data triangulation, which looks at the market from three perspectives.
Enquiry before buy @ https://www.research2reports.com/enquiry-before-buy-medical-devices/artemisinin-market/52016
Contact Information:
Research2reports
Jeet Rajput
Tel: 2026126969
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research2reports
Jeet Rajput
Tel: 2026126969
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results